Numerous individuals have sued over Tepzza’s side effects throughout the country, but no class action lawsuit has been filed. However, a motion to transfer the case to multidistrict litigation (MDL) was filed on March 22, 2023, requesting that all Tepezza cases be transferred to the Northern District of California.